Zebris Launches New JMAOptic Mandibular Motion Analysis System Enabling 3D Visualization of Jaw Movement

VCBeat (WeChat ID: vcbeat) has recently learned that Zebris Medical GmbH, a leader in biomechanics, has officially released its latest mandibular movement analysis system, “JMAOptic”.

“JMAOptic,” a flagship product in dental digitalization, can be applied across multiple dental specialties to help clinicians capture dynamic mandibular data, thereby enabling more comprehensive analysis for dental diagnosis and treatment. Against the backdrop of widespread digital transformation in dentistry, how does JMAOptic help clinicians improve efficiency and reduce costs? VCBeat provides an analysis.

According to available information, Zebris Medical GmbH, founded in 1987, is an innovative technology company specializing in biomechanics research. Headquartered in Isny im Allgäu, Germany, the company boasts over 25 years of expertise in the field of biomechanics. Zebris’s services are readily accessible across various sectors, including dentistry, healthcare, and competitive sports.

Since 2001, Zebris has been manufacturing its first generation of digital electronic mandibular analysis devices. Through five iterations, it has firmly established its leading position in the dental digitalization industry.

Currently, its sales network spans 35 countries and regions worldwide. Its various motion analysis systems can be used in orthopedics, neurorehabilitation, movement correction, dentistry, research institutions, etc.

Zebris’s newly released “JMAOptic” system is dedicated to the simple and convenient comprehensive visualization of patient mandibular movement data. Its core functionality assists dentists in performing complete and rapid diagnostic analyses of the stomatognathic system, while seamlessly integrating with subsequent prosthetic fabrication workflows to enable a fully precise treatment process.

This will provide assistance in the fully digital treatment of oral conditions, as well as in the management of more complex disorders such as malocclusion and temporomandibular joint disorders.

The all-new “JMAOptic” employs state-of-the-art measurement technology and incorporates auxiliary features such as Wi-Fi data transmission and wireless charging, thereby significantly enhancing the overall patient measurement experience. Additionally, the accompanying “WINJAW+RC” software further expands its compatibility by interfacing with major international intraoral scanning systems, enabling dynamic simulation of occlusal movements and assisting prosthodontists in identifying occlusal interferences.

It has been reported that the Zebris “JMAOptic” system holds technological advantages in the field of mandibular movement measurement. Its unique and user-friendly diagnostic and therapeutic functions, such as “condylar convexity analysis” and “determination of centric jaw relation,” are also key factors contributing to the system’s widespread recognition in Europe.

In addition, Zebris has established partnerships with several globally renowned articulator brands in the dental industry, including KAVO, Amann Girrbach, Ivoclar Vivadent, and SAM. Since 2020, Zebris’s unique “Articulator Measurement Module” has served as the articulator transfer solution for these brands. Specifically, Zebris provides OEM versions of its “electronic facebow” to these companies, thereby offering them a complete digital equipment portfolio and enhancing their respective brand value.

Mr. Wolfgang Brunner, co-founder of Zebris, stated, “At this stage, physicians and specialists specializing in the treatment of temporomandibular joint disorders (TMD) are relatively scarce in every country. In China, foundational dental education also severely lacks content on gnathology, with many clinicians long regarding it as ‘esoteric.’ Prior to the availability of dynamic mandibular data, temporomandibular joint disorders remained among the conditions most difficult to diagnose and treat effectively.”

Now, advancements in modern technology have enabled dentists to diagnose occlusal conditions from the dynamic dimension of mandibular movement, which is of great significance for occlusal reconstruction in special cases.

Liu Jin, General Manager of Beijing Weikai Digital Technology Co., Ltd., the Greater China representative office of Zebris, stated: “Over the past five years in China, we have clearly observed that gnathology courses and occlusion-related training have garnered significant attention and enthusiasm from many clinicians. By analyzing the learning interest curve, which rose in the early stages, plateaued or even declined two to three years ago, and has rapidly increased again over the last two years, we found that a major factor influencing the popularity of imaging gnathology education is the abstruse nature of the theories and the difficulty in obtaining evidence-based support.”

Liu Jin also mentioned that the past two years have seen a renewed surge in learning, driven by the increasing maturity of digital technologies. Theories that were once abstruse are now presented on screens through three-dimensional visualization on computers, effectively assisting physicians in disease diagnosis and treatment.

“In the German market as we understood it in 2018, digital systems related to occlusion had an annual procurement base ranging from hundreds to thousands of units, whereas in China, adoption was still in its early, exploratory stage. We are highly confident in the future of China’s occlusion market, particularly the digital occlusion segment. We will continue to introduce more courses and solutions to support and drive the development of China’s dental market,” Liu Jin concluded.

In addition, Zebris Medical GmbH is not only involved in the field of dentistry; its gait and plantar pressure measurement systems, developed and manufactured by the company, can assist in the early identification of individuals at high risk for diabetic foot in clinical settings, as well as support research and treatment of osteoarticular diseases and quantitative assessment of orthopedic surgical outcomes.

Zebris Medical GmbH is a technology-driven company leveraging innovative technologies to develop motion measurement and analysis systems in the field of biomechanics. With over 25 years of expertise in biomechanics, the company has achieved significant success in manufacturing and sales. Zebris’s solutions are widely accessible across various sectors, including dentistry, healthcare, and sports performance.

Zebris develops and manufactures its human motion analysis measurement systems at its facility in Isny im Allgäu, Germany. These systems are distributed worldwide through partners in 35 countries. They are suitable for use in various dental departments, orthopedic and neurological rehabilitation units, private clinics, and research institutions.